According to Alembic Pharmaceuticals's latest financial reports the company has $19.09 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $9.19 M | 14.12% |
2022-03-31 | $8.05 M | -79.24% |
2021-03-31 | $38.8 M | 307.32% |
2020-03-31 | $9.52 M | -66.77% |
2019-03-31 | $28.67 M | 94.59% |
2018-03-31 | $14.73 M | -37.64% |
2017-03-31 | $23.62 M | -64.31% |
2016-03-31 | $66.19 M | 1716.4% |
2015-03-31 | $3.64 M | -8.99% |
2014-03-31 | $4 M | 34.94% |
2013-03-31 | $2.96 M | -67.95% |
2012-03-31 | $9.25 M | 556.62% |
2011-03-31 | $1.4 M |